SCHEMBL6987662

SCHEMBL6987662

Cc1ccc(-c2cc(=O)c3cc(C#N)ccc3[nH]2)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.71
KDM4E B2RXH2 9/20 0.71
RAB9A P51151 7/20 0.71
SMN1; SMN2 Q16637 7/20 0.71
ALDH1A1 P00352 7/20 0.71
NPC1 O15118 6/20 0.71
MEN1 O00255 5/20 0.71
KMT2A Q03164 5/20 0.71
LMNA P02545 4/20 0.71
MAPK1 P28482 1/20 0.71
CTSV O60911 1/20 0.61
CTSL P07711 1/20 0.61
MAPT P10636 3/20 0.59
TP53 P04637 1/20 0.59
HSD17B10 Q99714 1/20 0.59
PDE10A Q9Y233 1/20 0.47
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15073406 0.80 CYP19A1 (0.72) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL9180105 0.79 ALDH1A1 (0.62) HPGDKDM4EALDH1A1MEN1KMT2A
SCHEMBL13038842 0.78 CTSV (0.69) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL6534180 0.76 HPGD (1.00) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL30935678 0.76 HPGD (1.00) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL2799465 0.75 HPGD (1.00) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL30573072 0.75 L3MBTL1 (0.44) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL26607165 0.75 L3MBTL1 (0.44) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1
SCHEMBL16923633 0.74 CHUK (0.57) HPGDKDM4EALDH1A1NPC1MEN1
SCHEMBL16382899 0.74 CYP19A1 (0.63) HPGDKDM4ERAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276739-A2 HETEROCYCLES THAT ARE INHIBITORS OF IMPDH ENZYME Bristol-Myers Squibb Company (US) 2003-01-22 EP disclosed
WO-2001081340-A2 HETEROCYCLES THAT ARE INHIBITORS OF IMPDH ENZYME BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-01 WO disclosed